Meyka Pro banner
Smith & Nephew plc

Smith & Nephew plc (SNN) Stock Overview

Explore Smith & Nephew plc’s financial performance, market position, analyst ratings, and future outlook.

SNNNYSE
HealthcareMedical - Devices
$30.11
$0.27(0.90%)
U.S. Market opens in 3h 2m

Smith & Nephew plc (SNN)

Meyka AI Score

Z

Key Financials

Market Cap12.7B
P/E Ratio20.08
EPS (TTM)$2.13
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$31.21
3 Months$25.94
1 Year Target$34.50

SNN Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Smith & Nephew plc (NYSE: SNN) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Smith & Nephew plc's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SNN on the NYSE shows an RSI of 46.64, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $34.50 for the NYSE listing.

Key metrics behind Smith & Nephew plc's NYSE-traded stock include a P/E ratio of 20.08 and a market capitalization of 12.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SNN on the NYSE.

Price Performance (NYSE: SNN)

1-Day Change
0.97%
5-Day Change
0.57%
1-Month Change
-3.06%
3-Month Change
1.04%
6-Month Change
-16.72%
Year-to-Date (YTD) Change
-8.17%
1-Year Change
-18.08%
3-Year Change
7.45%
5-Year Change
-21.19%
All-Time (Max) Change
265.21%

Contact Information

44 1923 477 100
Building 5 Croxley Park Hatters Lane, Watford, HRT, WD18 8YE

Company Facts

183,620 Employees
IPO DateNov 16, 1999
CountryGB
Actively Trading

Frequently Asked Questions